Literature DB >> 25449314

The leucine-rich amelogenin protein (LRAP) is primarily monomeric and unstructured in physiological solution.

Barbara J Tarasevich1, John S Philo2, Nasib Karl Maluf2, Susan Krueger3, Garry W Buchko1, Genyao Lin4, Wendy J Shaw1.   

Abstract

Amelogenin proteins are critical to the formation of enamel in teeth and may have roles in controlling growth and regulating microstructures of the intricately woven hydroxyapatite (HAP). Leucine-rich amelogenin protein (LRAP) is a 59-residue splice variant of amelogenin and contains the N- and C-terminal charged regions of the full-length protein thought to control crystal growth. Although the quaternary structure of full-length amelogenin in solution has been well studied and can consist of self-assemblies of monomers called nanospheres, there is limited information on the quaternary structure of LRAP. Here, sedimentation velocity analytical ultracentrifugation (SV) and small angle neutron scattering (SANS) were used to study the tertiary and quaternary structure of LRAP at various pH values, ionic strengths, and concentrations. We found that the monomer is the dominant species of phosphorylated LRAP (LRAP(+P)) over a range of solution conditions (pH 2.7-4.1, pH 4.5-8, 50 mmol/L(mM) to 200 mM NaCl, 0.065-2 mg/mL). The monomer is also the dominant species for unphosphorylated LRAP (LRAP(-P)) at pH 7.4 and for LRAP(+P) in the presence of 2.5 mM calcium at pH 7.4. LRAP aggregates in a narrow pH range near the isoelectric point of pH 4.1. SV and SANS show that the LRAP monomer has a radius of ∼2.0 nm and an asymmetric structure, and solution NMR studies indicate that the monomer is largely unstructured. This work provides new insights into the secondary, tertiary, and quaternary structure of LRAP in solution and provides evidence that the monomeric species may be an important functional form of some amelogenins.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amelogenin; Biomineralization; Enamel; LRAP; Nanosphere

Mesh:

Substances:

Year:  2014        PMID: 25449314      PMCID: PMC4400868          DOI: 10.1016/j.jsb.2014.10.007

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  60 in total

1.  The nucleation and growth of calcium phosphate by amelogenin.

Authors:  Barbara J Tarasevich; Christopher J Howard; Jenna L Larson; Malcolm L Snead; James P Simmer; Michael Paine; Wendy J Shaw
Journal:  J Cryst Growth       Date:  2007-06-15       Impact factor: 1.797

2.  Identification of the leucine-rich amelogenin peptide (LRAP) as the translation product of an alternatively spliced transcript.

Authors:  C W Gibson; E Golub; W D Ding; H Shimokawa; M Young; J Termine; J Rosenbloom
Journal:  Biochem Biophys Res Commun       Date:  1991-02-14       Impact factor: 3.575

3.  Protein interactions during assembly of the enamel organic extracellular matrix.

Authors:  M L Paine; M L Snead
Journal:  J Bone Miner Res       Date:  1997-02       Impact factor: 6.741

4.  Comparison of the crystal and solution structures of calmodulin and troponin C.

Authors:  D B Heidorn; J Trewhella
Journal:  Biochemistry       Date:  1988-02-09       Impact factor: 3.162

5.  Dissecting amelogenin protein nanospheres: characterization of metastable oligomers.

Authors:  Keith M Bromley; Andrew S Kiss; Sowmya Bekshe Lokappa; Rajamani Lakshminarayanan; Daming Fan; Moise Ndao; John Spencer Evans; Janet Moradian-Oldak
Journal:  J Biol Chem       Date:  2011-08-12       Impact factor: 5.157

6.  Comparative calcium binding of leucine-rich amelogenin peptide and full-length amelogenin.

Authors:  Thuan Q Le; Miriam Gochin; John D B Featherstone; Wu Li; Pamela K DenBesten
Journal:  Eur J Oral Sci       Date:  2006-05       Impact factor: 2.612

Review 7.  Bone sialoprotein.

Authors:  B Ganss; R H Kim; J Sodek
Journal:  Crit Rev Oral Biol Med       Date:  1999

8.  The COOH terminus of the amelogenin, LRAP, is oriented next to the hydroxyapatite surface.

Authors:  Wendy J Shaw; Allison A Campbell; Michael L Paine; Malcolm L Snead
Journal:  J Biol Chem       Date:  2004-08-05       Impact factor: 5.157

9.  Determination of the conformations of cAMP receptor protein and its T127L,S128A mutant with and without cAMP from small angle neutron scattering measurements.

Authors:  S Krueger; I Gorshkova; J Brown; J Hoskins; K H McKenney; F P Schwarz
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

10.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

View more
  5 in total

1.  Dynamic interactions of amelogenin with hydroxyapatite surfaces are dependent on protein phosphorylation and solution pH.

Authors:  Christopher Connelly; Thomas Cicuto; Jason Leavitt; Alexander Petty; Amy Litman; Henry C Margolis; Aren E Gerdon
Journal:  Colloids Surf B Biointerfaces       Date:  2016-09-08       Impact factor: 5.268

2.  Controls of nature: Secondary, tertiary, and quaternary structure of the enamel protein amelogenin in solution and on hydroxyapatite.

Authors:  Wendy J Shaw; Barbara J Tarasevich; Garry W Buchko; Rajith M J Arachchige; Sarah D Burton
Journal:  J Struct Biol       Date:  2020-09-24       Impact factor: 2.867

3.  Dose-Dependent Rescue of KO Amelogenin Enamel by Transgenes in Vivo.

Authors:  Felicitas B Bidlack; Yan Xia; Megan K Pugach
Journal:  Front Physiol       Date:  2017-11-16       Impact factor: 4.566

4.  Protein Phosphorylation and Mineral Binding Affect the Secondary Structure of the Leucine-Rich Amelogenin Peptide.

Authors:  Hajime Yamazaki; Elia Beniash; Yasuo Yamakoshi; James P Simmer; Henry C Margolis
Journal:  Front Physiol       Date:  2017-06-29       Impact factor: 4.566

5.  Amelogenin is a Potential Biomarker for the Aggressiveness in Odontogenic Tumors

Authors:  Safa Zakaraia; Mamdouh Almohareb; Khaled Zaid; Mazen Doumani; Mohammad Yaman Seirawan
Journal:  Asian Pac J Cancer Prev       Date:  2018-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.